BioSpace News Archive

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced a volunteer program to enable clinically-qualified employees to address the UK government’s call for volunteers to support COVID-19 testing.

Sage Therapeutics, Inc. announced that on April 1, 2020, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 540 shares of its common stock, and 90 performance restricted stock units to one new employee under Sage’s 2016 Inducement Equity Plan.

A world-renowned leader in infectious disease and transfusion medicine research, Vitalant Research Institute (VRI)—a division of Vitalant, the nation’s largest independent blood service provider—is helping direct collection and processing of blood plasma donations from recovered COVID-19 patients and developing technologies to det

PharmAbcine Inc. (KOSDAQ: 208340) announced today that the abstract summarizing interim data on its phase Ib trial of olinvacimab in combination with Merck’s anti-PD-1 antibody Keytruda® for recurrent glioblastoma multiforme (rGBM) patients has been accepted at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting.

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that it is providing GIAPREZA™ (angiotensin II) for named patient emergency use in patients with septic shock due to COVID-19 at University Hospital Frankfurt in Germany.

As Save a Child’s Heart’s finished heart surgery on its last child until the pandemic ends, SACH announced that it is teaming up with Wolfson Medical Center, a hospital serving 500,000 people in central Israel, to make space for patients and raise money for essential medical supplies needed for the hospital’s fight against COVID-19.